Listen on the go
CORRECT!
Next question
touchINFECTIOUS DISEASES touchINFECTIOUS DISEASES

Start Learning

Touch Loading image
Alex Soriano rezafungin
CONFERENCE HUB
Start Learning
ReSTORE trial: rezafungin in candidemia and invasive candidiasis – Alex Soriano, ECCMID 2023
CONFERENCE HUB
Start Learning
Nyaradzo Mgodi, CROI 2023: HIV prevention in practice – Unmet needs and clinical evidence for long acting cabotegravir in at-risk populations
CONFERENCE HUB
Start Learning
NeoCHG: efficacy and safety of chlorhexidine gluconate skin application for sepsis in neonates: Michelle Clements, ECCMID 2023
CONFERENCE HUB
Start Learning
Patient Perspective, Yvette Raphael: Inclusivity of women and underrepresented populations in HIV clinical trials
CONFERENCE HUB
Start Learning
ECCMID 2023 highlights in fungal infections – diagnostics, treatments and case reports: Mahmoud Ghannoum
touchIN CONVERSATION
Start Learning
Practical considerations for COVID-19 vaccination in the Middle East
CE/CME ACCREDITED
CONFERENCE HUB
Start Learning
Viki Male: Navigating concerns about menstrual cycle changes after COVID-19 vaccination
JOURNALS
Start Learning
Dementia and Cognitive Concerns as Risk Factors in People with COVID-19 and HIV
CONFERENCE HUB
Start Learning
PHH-1V vaccine compared to BNT162b2 as a SARS-CoV-2 booster vaccine, phase IIb results: Patricia Muñoz García, ECCMID 2023
Christoph-Spinner COVID
CONFERENCE HUB
Start Learning
COVID-19 vaccine development, updates and advances: Christoph Spinner, ECCMID 2023

to view Favourites, Keep Notes and Track CME Credits

Favourites
Shaping ART around individual needs: Maximizing adherence and quality of life
View
Preventing HPV-associated cancer by maximizing vaccine uptake
View
ReSTORE trial: rezafungin in candidemia and invasive candidiasis – Alex Soriano, ECCMID 2023
View
ECCMID 2023 highlights in nosocomial infection – diagnostics and molecular testing: Alex Soriano
View
Viki Male: COVID-19 infection and vaccination during pregnancy and breastfeeding, understanding the risks and benefits
View
The mRNA vaccine platform: A novel tool for the rapid development of vaccines against respiratory viral infections
View
Bictegravir / Emtricitabine / Tenofovir Alafenomide for the Treatment of HIV / Hepatitis B Virus Co-infection in Patients with Cancer and Transplant Recipients
View
ECCMID 2023 highlights in fungal infections – diagnostics, treatments and case reports: Mahmoud Ghannoum
View
Updated HIV primary care guidelines: Mamta Jain, ACTHIV 2023
View
Clostridioides difficile infection in paediatric patients: unmet needs and future challenges: Anne J. Gonzales-Luna, ECCMID 2023
View
Copied to clipboard!
accredited arrow-down-editablearrow-downarrow_leftarrow-right-bluearrow-right-dark-bluearrow-right-greenarrow-right-greyarrow-right-orangearrow-right-whitearrow-right-bluearrow-up-orangeavatarcalendarchevron-down consultant-pathologist-nurseconsultant-pathologistcrosscrossdownloademailexclaimationfeedbackfiltergraph-arrowinterviewslinkmdt_iconmenumore_dots nurse-consultantpadlock patient-advocate-pathologistpatient-consultantpatientperson pharmacist-nurseplay_buttonplay-colour-tmcplay-colourAsset 1podcastprinter scenerysearch share single-doctor social_facebooksocial_googleplussocial_instagramsocial_linkedin_altsocial_linkedin_altsocial_pinterestlogo-twitter-glyph-32social_youtubeshape-star (1)tick-bluetick-orangetick-red tick-whiteticktimetranscriptup-arrowwebinar Sponsored Department Location NEW TMM Corporate Services Icons-07NEW TMM Corporate Services Icons-08NEW TMM Corporate Services Icons-09NEW TMM Corporate Services Icons-10NEW TMM Corporate Services Icons-11NEW TMM Corporate Services Icons-12Salary £ TMM-Corp-Site-Icons-01TMM-Corp-Site-Icons-02TMM-Corp-Site-Icons-03TMM-Corp-Site-Icons-04TMM-Corp-Site-Icons-05TMM-Corp-Site-Icons-06TMM-Corp-Site-Icons-07TMM-Corp-Site-Icons-08TMM-Corp-Site-Icons-09TMM-Corp-Site-Icons-10TMM-Corp-Site-Icons-11TMM-Corp-Site-Icons-12TMM-Corp-Site-Icons-13TMM-Corp-Site-Icons-14TMM-Corp-Site-Icons-15TMM-Corp-Site-Icons-16TMM-Corp-Site-Icons-17TMM-Corp-Site-Icons-18TMM-Corp-Site-Icons-19TMM-Corp-Site-Icons-20TMM-Corp-Site-Icons-21TMM-Corp-Site-Icons-22TMM-Corp-Site-Icons-23TMM-Corp-Site-Icons-24TMM-Corp-Site-Icons-25TMM-Corp-Site-Icons-26TMM-Corp-Site-Icons-27TMM-Corp-Site-Icons-28TMM-Corp-Site-Icons-29TMM-Corp-Site-Icons-30TMM-Corp-Site-Icons-31TMM-Corp-Site-Icons-32TMM-Corp-Site-Icons-33TMM-Corp-Site-Icons-34TMM-Corp-Site-Icons-35TMM-Corp-Site-Icons-36TMM-Corp-Site-Icons-37TMM-Corp-Site-Icons-38TMM-Corp-Site-Icons-39TMM-Corp-Site-Icons-40TMM-Corp-Site-Icons-41TMM-Corp-Site-Icons-42TMM-Corp-Site-Icons-43TMM-Corp-Site-Icons-44TMM-Corp-Site-Icons-45TMM-Corp-Site-Icons-46TMM-Corp-Site-Icons-47TMM-Corp-Site-Icons-48TMM-Corp-Site-Icons-49TMM-Corp-Site-Icons-50TMM-Corp-Site-Icons-51TMM-Corp-Site-Icons-52TMM-Corp-Site-Icons-53TMM-Corp-Site-Icons-54TMM-Corp-Site-Icons-55TMM-Corp-Site-Icons-56TMM-Corp-Site-Icons-57TMM-Corp-Site-Icons-58TMM-Corp-Site-Icons-59TMM-Corp-Site-Icons-60TMM-Corp-Site-Icons-61TMM-Corp-Site-Icons-62TMM-Corp-Site-Icons-63TMM-Corp-Site-Icons-64TMM-Corp-Site-Icons-65TMM-Corp-Site-Icons-66TMM-Corp-Site-Icons-67TMM-Corp-Site-Icons-68TMM-Corp-Site-Icons-69TMM-Corp-Site-Icons-70TMM-Corp-Site-Icons-71TMM-Corp-Site-Icons-72